Want to see HK:1541 full AI Analyst Report?
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Financial Statements
3 Followers
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Financial Overview
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's market cap is currently ¥1.24B. The company's EPS TTM is ¥-0.53; its P/E ratio is -4.62; ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 150.30M | ¥ 74.15M | ¥ 386.00K | ¥ 5.69M | ¥ 13.81M |
| Gross Profit | ¥ 134.99M | ¥ 74.15M | ¥ 7.70M | ¥ 5.69M | ¥ 13.81M |
| Operating Income | ¥ -217.26M | ¥ -308.04M | ¥ -364.67M | ¥ -364.45M | ¥ -210.47M |
| EBITDA | ¥ -203.03M | ¥ -287.36M | ¥ -355.35M | ¥ -384.49M | ¥ -718.88M |
| Net Income | ¥ -212.92M | ¥ -315.86M | ¥ -379.46M | ¥ -402.89M | ¥ -732.95M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.02B | ¥ 752.12M | ¥ 608.56M | ¥ 635.21M | ¥ 668.33M |
| Total Assets | ¥ 1.10B | ¥ 922.00M | ¥ 874.59M | ¥ 839.98M | ¥ 892.84M |
| Total Debt | ¥ 228.12M | ¥ 136.36M | ¥ 74.77M | ¥ 14.62M | ¥ 18.54M |
| Net Debt | ¥ -451.73M | ¥ -341.24M | ¥ -232.21M | ¥ -620.59M | ¥ -649.79M |
| Total Liabilities | ¥ 308.40M | ¥ 243.69M | ¥ 126.30M | ¥ 60.76M | ¥ 2.49B |
| Stockholders' Equity | ¥ 791.78M | ¥ 678.90M | ¥ 748.29M | ¥ 779.22M | ¥ -1.60B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -197.13M | ¥ -138.44M | ¥ -370.25M | ¥ -261.93M | ¥ -315.79M |
| Operating Cash Flow | ¥ -195.85M | ¥ -128.03M | ¥ -367.55M | ¥ -238.71M | ¥ -190.54M |
| Investing Cash Flow | ¥ 2.82M | ¥ 37.95M | ¥ -294.85M | ¥ 49.00K | ¥ -108.72M |
| Financing Cash Flow | ¥ 397.11M | ¥ 258.93M | ¥ 331.04M | ¥ 179.38M | ¥ 793.03M |
Currency in CNY
